MRPs of 390 cancer medicines cut by 87% after price control order
New Delhi, March 8 -- The maximum retail price (MRP) of 390 non-scheduled cancer medicines have been reduced by up to 87%, the government said Friday, days after India's drug pricing regulator brought 42 non-scheduled cancer drugs under price control-capping their trade margin at 30%. The move would result in annual savings of around Rs.800 crore for patients, the government said....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.